Form 4: KWR Executive Andre Frodl Reports Equity Transactions

Sentiment:

Insider Transaction Report


Quaker Chemical Corp's VP of R&D, Andre Frodl, reported the vesting of performance and restricted stock units, along with tax-related share dispositions and a new RSU grant.

Summary

  • Andre Frodl, VP, R&D-Metals & Metalworking at Quaker Chemical Corp (KWR), reported several equity transactions on March 15, 2026.
  • Acquired 72 shares of common stock from the vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, based on achieving adjusted return on invested capital (ROIC) metrics over a three-year period.
  • Converted various Restricted Stock Units (RSUs) into a total of 233 shares of common stock (60+60+93+20).
  • Settled 4 Dividend Equivalent Rights (DERs) into common stock, which accrued on RSUs granted in 2023, 2024, and 2025.
  • Disposed of 149 shares of common stock at a price of $118.45 per share to cover withholding tax obligations related to the vesting of RSUs and PSUs.
  • Received a new grant of 371 time-based Restricted Stock Units (RSUs) under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments starting March 15, 2027.
  • Following these transactions, Andre Frodl directly beneficially owned 771 shares of common stock and 371 derivative Restricted Stock Units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, reflecting the successful achievement of performance metrics for PSU vesting and the continued alignment of executive incentives through new RSU grants, offset slightly by routine tax-related share dispositions.

Positives

  • Vesting of Performance Stock Units (PSUs) indicates the company achieved its adjusted return on invested capital (ROIC) metric over the three-year performance period.
  • The executive received a new grant of 371 time-based Restricted Stock Units, aligning management incentives with long-term shareholder value.

Negatives

  • Disposition of 149 shares to cover tax obligations represents a reduction in direct beneficial ownership of common stock.

Future Outlook

The new grant of 371 time-based Restricted Stock Units, vesting in three annual installments beginning March 15, 2027, indicates a continued long-term incentive structure for the executive.

Industry Context

StockSavvy.ai notes that equity compensation, including PSUs and RSUs, is a standard practice in the specialty chemicals industry to align executive incentives with company performance and shareholder returns. The vesting of PSUs tied to ROIC suggests a focus on capital efficiency, a key driver in capital-intensive sectors like chemicals.

Comparison to Industry Standards

  • Equity compensation plans, including performance-based (PSUs) and time-based (RSUs) awards, are common across publicly traded companies, particularly in the industrial and materials sectors, to attract and retain executive talent.
  • Tying PSU vesting to metrics like Return on Invested Capital (ROIC) is a best practice for aligning executive incentives with long-term value creation, similar to companies like DuPont or BASF, which emphasize capital efficiency in their executive compensation structures.
  • The practice of surrendering shares for tax withholding upon vesting is a standard mechanism for managing tax liabilities associated with equity awards, observed in most corporate compensation programs.

Stakeholder Impact

  • Shareholders: The vesting of performance-based awards suggests the company met certain financial targets (ROIC), which is generally positive for shareholders. The new RSU grant aligns executive interests with long-term shareholder value.
  • Employees: The filing pertains to executive compensation and does not directly impact the broader employee base, though it reflects the company's compensation philosophy.

Next Steps

  • The 371 time-based RSUs granted on March 15, 2026, will vest in three annual installments beginning on March 15, 2027.

Key Dates

DateDescription
03/15/2023Award date for Performance Stock Units (PSUs) and 179 time-based RSUs.
03/15/2024First annual installment vesting date for 2023 RSUs; award date for 179 time-based RSUs.
03/15/2025First annual installment vesting date for 2024 RSUs; award date for 280 time-based RSUs.
10/15/2025Award date for 61 special time-based RSUs.
03/15/2026Date of earliest transaction; vesting and settlement date for PSUs, RSUs, and DERs; first annual installment vesting date for 2025 and October 2025 RSUs; award date for 371 time-based RSUs.
03/17/2026Signature date of the reporting person's attorney-in-fact.
03/15/2027First annual installment vesting date for the 371 time-based RSUs granted on March 15, 2026.

Recommendation

hold

This Form 4 filing details routine executive compensation events, including the vesting of performance and restricted stock units and subsequent tax-related share dispositions, along with a new RSU grant. These transactions are expected and do not indicate a material change in the company's operational or financial outlook, nor do they signal a strong buy or sell signal from insider activity. Therefore, a 'hold' recommendation is appropriate as these are standard compensation disclosures.

Keywords

Quaker Chemical Corp, KWR, Andre Frodl, SEC Form 4, Insider Transaction, Restricted Stock Units, Performance Stock Units, Equity Compensation, Stock Vesting, Dividend Equivalent Rights

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.